JASPER THERAPEUTICS INC (JSPR)

US4718712023 - Common Stock

22.05  +0.21 (+0.96%)

After market: 22.05 0 (0%)

Buy % Consensus

86

ChartMill assigns a Buy % Consensus number of 86% to JSPR. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 73.06. This target is 231.33% above the current price.
JSPR was analyzed by 17 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about JSPR.
In the previous month the buy percentage consensus was at a similar level.
JSPR was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 22.0555.5570.3873.0694.50 - 151.93% 219.18% 231.33% 328.57%
Up and Down Grades
Date Firm Action Rating
2024-10-24 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-15 JMP Securities Reiterate Market Outperform -> Market Outperform
2024-10-15 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-27 JMP Securities Reiterate Market Outperform -> Market Outperform
2024-09-09 Cantor Fitzgerald Reiterate Overweight
2024-09-09 JMP Securities Initiate Market Outperform
2024-08-26 Evercore ISI Group Maintains Outperform -> Outperform
2024-08-14 RBC Capital Maintains Outperform -> Outperform
2024-08-13 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-05 HC Wainwright & Co. Reiterate Buy -> Buy
2024-07-08 BTIG Initiate Buy
2024-06-27 Stifel Initiate Buy
2024-06-18 Cantor Fitzgerald Reiterate Overweight
2024-05-20 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-15 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-06 HC Wainwright & Co. Initiate Buy
2024-04-03 Evercore ISI Group Initiate Outperform
2024-03-28 RBC Capital Initiate Outperform
2024-03-18 TD Cowen Initiate Outperform
2024-03-07 Oppenheimer Maintains Outperform -> Outperform
2023-10-12 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-08-14 Credit Suisse Reiterate Outperform -> Outperform
2023-08-11 Capital One Initiate Overweight
2023-06-12 EF Hutton Reiterate Buy -> Buy
2023-05-16 Oppenheimer Reiterate Outperform -> Outperform
2023-05-15 EF Hutton Reiterate Buy -> Buy
2023-05-15 Credit Suisse Reiterate Outperform -> Outperform
2023-03-09 EF Hutton Reiterate Buy
2023-03-09 Cantor Fitzgerald Reiterate Overweight
2023-03-09 Credit Suisse Reiterate Outperform